Angle raises £20 million in discounted placing to accelerate growth
- Company raises £20.13 million at 14.4% discount- Funds will accelerate multiple pathways to commercialisation, claims company- Hopes to exploit first mover advantageLiquid biopsy company ANGLE (AGL:AIM) has raised £20.13 million in gross proceeds following a successful placing of new shares at 80p per share, with a retail investor offer included.Chief executive Andrew Newland and chief financi